Write in a clean editor, then format for Frontiers in Microbiomes in one click — DocuGuru applies the official Frontiers template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Microbiomes is a peer-reviewed journal published by Frontiers, covering Gut microbiota and health, Clostridium difficile and Clostridium perfringens research, Microbial Community Ecology and Physiology. Over its lifetime it has published 248 papers, which have received 1,209 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Frontiers in Microbiomes, 12(3), pp. 45–58.
Formats any DOI in Frontiers in Microbiomes style. No sign-up. |
| Publishes research in | Gut microbiota and health Clostridium difficile and Clostridium perfringens research Microbial Community Ecology and Physiology Probiotics and Fermented Foods Diet and metabolism studies |
| ISSN | 2813-4338 |
| Citation impact (2-yr) | 3.22 |
| h-index | 15 |
| i10-index | 31 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Centre National de la Recherche Scientifique |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Gut microbiota has been reported to be closely related to host energy metabolism and immunity, and thus influence the development and progression of various human diseases. To date, the gut microbial metabolites such as short-chain fatty acids, defensins, cathelicidins, and lactoferrin in feces have been investigated as biomarkers associated with various disease conditions. In this…
The recent FDA approvals of Rebyota™ and Vowst™ represent landmark milestones within the burgeoning field of live microbiota-based products. Future microbiota-based treatment approaches also hold significant promise for treating patients with a myriad of diseases and disorders, yet substantial hurdles hinder their development and utilization. Foremost, existing regulatory frameworks governing live biotherapeutic product (LBP) manufacturing…
Postbiotics, which are bioactive compounds derived from the metabolic processes of probiotics, are gaining recognition as a promising alternative for managing chronic diseases without the need for live microorganisms, positioning them as a valuable strategy in biotherapeutics that offers both curative and preventive techniques in modern medicine. This paper provides a comprehensive review of the…
dominance and increase of microbial diversity, has been linked to an increased risk of adverse genital tract diseases, including bacterial vaginosis, aerobic vaginitis, vulvovaginal candidiasis, sexually transmitted infections, and pregnancy complications such as preterm birth. Currently, antibiotics and antifungals are recommended first-line treatments with high cure rates, but they also can lead to high recurrence…
Two factors that are well-known to influence soil microbiomes are the depth of the soil as well as the level of moisture. Previous works have demonstrated that climate change will increase the incidence of drought in soils, but it is unknown how fluctuations in moisture availability affect soil microbiome composition and functioning down the depth…
